Vol 14, No 5 (October 31, 2025): Chinese Clinical Oncology

Original Article

The joint impact of sleep duration and physical activity on all-cause and cancer-specific mortality in cancer survivors: a retrospective cohort study based on NHANES 2005–2018
Jiao Wang, Tao Li
Chinese Clinical Oncology  
2025;
14
(5)
:50
.
 (31 October 2025) 
PDF Full Text (330) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Efficacy and safety of atezolizumab compared to docetaxel in non-small cell lung cancer patients regardless of PD-L1 status: a systematic review and meta-analysis
Ximing Li, Hai Zhao, Yonghong Cui
Chinese Clinical Oncology  
2025;
14
(5)
:51
.
 (31 October 2025) 
PDF Full Text (228) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Breast cancer stage, molecular subtype and survival in patients with obesity: a real-world study
André Mattar, Marcelo Antonini, Francisco Pimentel Cavalcante, Felipe Zerwes, Eduardo Camargo Millen, Fabricio Palermo Brenelli, Antônio Luiz Frasson, Leonardo Ribeiro Soares, Marcelo Madeira, Marina Diógenes Teixeira, Andressa Gonçalves Amorim, Larissa Chrispim de Oliveira, Marcellus do Nascimento Moreira Ramos, Gil Facina, Ruffo Freitas-Junior, Henrique Lima Couto, Sabrina Monteiro Rondelo, Renata Montarroyos Leite, Renata Arakelian, Rogerio Fenile, Luiz Henrique Gebrim
Chinese Clinical Oncology  
2025;
14
(5)
:52
.
 (31 October 2025) 
PDF Full Text (275) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Afatinib for patients with non-small-cell lung cancer harboring major EGFR G719X + S768I co-mutations: a retrospective, observation study in Xuanwei and Fuyuan, China
Ruoyu Deng, Lin Wang, Jialing Lv, Feineng Liu, Tengfei Zhang, Chunyan Li, Chongxin Li, Zhijun Zhang, Huahua Zhou, Wen Zhang, Chao Zhang
Chinese Clinical Oncology  
2025;
14
(5)
:53
.
 (31 October 2025) 
PDF Full Text (251) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission

Review Article

The global impact of the General Data Protection Regulation: implications, challenges, and future outlook in oncology clinical research sponsors
Xiao Liu, Denis Lacombe, Stephane Lejeune
Chinese Clinical Oncology  
2025;
14
(5)
:54
.
 (31 October 2025) 
PDF Full Text (361) Peer Review File COI Form Open Access Get Permission
Neoadjuvant chemoimmunotherapy or chemoradiotherapy in stage III non-small cell lung cancer: crossing the Rubicon?
Juan Carlos Redondo-González, Luis Posado-Domínguez, Laura Corvo-Félix, José Pablo Miramontes-González, Emilio Fonseca-Sánchez, Edel del Barco-Morillo, Alejandro Olivares-Hernández
Chinese Clinical Oncology  
2025;
14
(5)
:55
.
 (31 October 2025) 
PDF Full Text (376) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Natural compounds targeting mitochondrial metabolism in cancer therapy: a literature review
Grazielle Silva Paz, Janaina Fernandes
Chinese Clinical Oncology  
2025;
14
(5)
:56
.
 (31 October 2025) 
PDF Full Text (556) Reporting Checklist Peer Review File COI Form Open Access Get Permission

Case Report

Induction chemotherapy followed by radiotherapy in primary small cell neuroendocrine carcinoma of the parotid gland: a case report and literature review
Ruoyu Deng, Lin Wang, Jialing Lv, Fang Wang, Tengfei Zhang, Feineng Liu, Chunyan Li, Wen Zhang, Chao Zhang
Chinese Clinical Oncology  
2025;
14
(5)
:57
.
 (31 October 2025) 
PDF Full Text (151) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Paclitaxel and carboplatin combination therapy-induced pure red cell aplasia in endometrial cancer patient and favorable response to low-dose corticosteroid treatment: a case report
Chengyulong Zheng, Meng Chen, Jiayu He, Ying Zhang, Lixiang Yan, Zhexin Shi
Chinese Clinical Oncology  
2025;
14
(5)
:58
.
 (31 October 2025) 
PDF Full Text (333) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Primary hyperparathyroidism due to water-clear cell carcinoma of the parathyroid gland: a case report and literature review
Leenah Abdulgader, Abdullah Esmail, Bayan Khasawneh, Ebtesam Al-Najjar, Ghazi Alharbi, Saad Al Awwad
Chinese Clinical Oncology  
2025;
14
(5)
:59
.
 (31 October 2025) 
PDF Full Text (158) Reporting Checklist Peer Review File COI Form Open Access Get Permission

Editorial Commentary

The value of up-front thoracic radiotherapy in the management of metastatic EGFR-mutated non-small cell lung cancer
Lucyna Kępka
Chinese Clinical Oncology  
2025;
14
(5)
:60
.
 (31 October 2025) 
PDF Full Text (160) Peer Review File COI Form Open Access Get Permission
The novel approach with antibody-drug conjugate targeting CLDN18.2 trial’s insights and future perspectives
Izuma Nakayama
Chinese Clinical Oncology  
2025;
14
(5)
:61
.
 (31 October 2025) 
PDF Full Text (322) Peer Review File COI Form Open Access Get Permission
Patient-related reported outcomes (PROs) from TALAPRO-2: the PROs and cons
Edoardo Francini
Chinese Clinical Oncology  
2025;
14
(5)
:62
.
 (31 October 2025) 
PDF Full Text (224) Peer Review File COI Form Open Access Get Permission
The potential of (177Lu)-PSMA-617 in the first-line combination therapy with enzalutamide for metastatic castration-resistant prostate cancer: clinical insights from the ENZA-p trial
Renning Zheng, Stephen J. Freedland, Anthony T. Nguyen
Chinese Clinical Oncology  
2025;
14
(5)
:63
.
 (31 October 2025) 
PDF Full Text (298) Peer Review File COI Form Open Access Get Permission

Letter to the Editor

Causal association between local infection of Epstein-Barr virus and gastric cancer risk: a rapid meta-analysis
Zhuo-Yu Li, Rui Wang, Xin-Zu Chen; on behalf of the SIGES Research Group
Chinese Clinical Oncology  
2025;
14
(5)
:64
.
 (31 October 2025) 
PDF Full Text (200) COI Form Open Access Get Permission